Business Context and Reporting Period
This Form 6-K, filed on October 8, 2025, reports the consummation of a business combination by Black Titan Corporation (a Cayman Islands exempted company). On October 1, 2025, Black Titan completed the acquisition of Titan Pharmaceuticals, Inc. (Titan) and TalenTec Sdn. Bhd. (TalenTec). Titan became a direct wholly-owned subsidiary of Black Titan via a merger, while TalenTec became a subsidiary via a share exchange. The combined entity's ordinary shares trade on Nasdaq under the symbol "BTTC."
Key Financial Metrics and Capital Structure
The filing details the capital structure immediately following the transaction but does not provide specific revenue, profit, or cash flow figures for the combined entity in this text; such data is incorporated by reference from the Proxy Statement/Prospectus.
- Share Issuance: 7,210,800 Black Titan Ordinary Shares were issued to TalenTec shareholders at an exchange ratio of 8.524 Black Titan shares for each TalenTec share.
- PIPE Financing: On October 1, 2025, Black Titan executed a drawdown of $5,500,000 under a subscription agreement with ARC Group Limited, issuing 5,500 Series A Convertible Preferred Shares. The total commitment for this facility was increased to $6,000,000 in August 2025.
- Outstanding Shares: As of October 1, 2025, there were 7,210,800 Ordinary Shares issued and outstanding (excluding the Series A Preferred Shares).
- Dividends: The company has not paid cash dividends and does not anticipate declaring any in the foreseeable future.
Material Changes and Ownership Structure
The primary material change is the completion of the business combination, resulting in a new ownership structure. Significant beneficial owners (holding >5%) as of October 1, 2025, include:
- Danny Vincent Dass: 2,344,100 shares (32.5% ownership).
- The Sire Group Ltd. / Jeffrey Chung: 1,019,313 shares (14.1% ownership).
- ARC Group Limited: 720,358 shares (9.9% ownership), representing the PIPE investor.
- Goh Chee Siong: 681,920 shares (9.5% ownership).
- Koay Chee Leong & Leow Kian Yong: 639,300 shares each (8.9% ownership each).
Executive officers and directors as a group hold 9,563 shares (less than 1%).
Guidance, Risks, and Management Commentary
Management and Governance: The Board of Directors consists of six members, four of whom are independent. Standing committees include Audit, Compensation, and Corporate Governance/Nominating. Specific executive compensation programs are yet to be finalized but will align with Nasdaq-listed peers.
Risks and Contingencies: The filing highlights significant risks including the ability to maintain Nasdaq listing, regulatory changes in operating jurisdictions (Malaysia, Cayman Islands, Delaware), political instability, cybersecurity threats, and the potential disruption of operations due to the business combination. Forward-looking statements are subject to uncertainties regarding market share growth and financing capabilities.
Unusual Items: Certain Titan warrants issued prior to the merger may be subject to a cashless exercise or purchase by the company at Black Scholes Value within 30 days of the merger consummation.
Investor Verification Checklist
- Verify the pro forma financial information in Exhibit 99.1 to assess the combined entity's liquidity and capital resources.
- Review the Proxy Statement/Prospectus (incorporated by reference) for detailed revenue, profit, and cash flow metrics of Titan and TalenTec.
- Confirm the terms of the Series A Convertible Preferred Shares, specifically the conversion price mechanism (85% of VWAP) and the remaining drawdown capacity ($500,000 of the $6,000,000 facility).
- Assess the registration rights granted to Danny Vincent Dass regarding the resale of his 2,344,100 shares.
- Monitor the company's ability to maintain Nasdaq listing requirements post-combination.